title: The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients.
abstract: The purpose of this paper is to discuss a hypothesis corroborating the use of hydrolytic enzymes in AIDS/ARC/LAS patients, showing high levels of circulating immune complexes (CIC). Other diseases, revealing high CIC-levels as well, may be improved or even cured by eliminating CIC. The results obtained from experiences of CIC-elimination by hydrolytic enzymes are presented below. As may be determined from the data available, hydrolytic enzymes should be included in the therapy of HIV-positive patients. Clinical trials are being continued.
authors.affiliation: Medizinische Enzymforschungsgesellschaft, Geretsried, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Stauder
authors.forename: K
authors.initials: K
authors.lastname: Ransberger
authors.forename: P
authors.initials: P
authors.lastname: Streichhan
authors.forename: W
authors.initials: W
authors.lastname: Van Schaik
authors.forename: W
authors.initials: W
authors.lastname: Pollinger
mesh_terms: D000386:AIDS-Related Complex / Q000188:drug therapy* / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000936:Antigen-Antibody Complex; D006801:Humans; D006867:Hydrolases / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010587:Phagocytosis; D010956:Plasmapheresis
chemical_list: D000936:Antigen-Antibody Complex; D007166:Immunosuppressive Agents; D006867:Hydrolases